Home > About Us > Our Management Team > Ruyi He
Ruyi He
Chief Medical Officer
Dr. He Ruyi, Chief Strategy Officer of the company, is an authority in the field of clinical development of pharmaceuticals in China and global regulatory systems. Dr. He Ruyi has worked in FDA and China's drug regulatory agency for nearly 20 years, of which over 17 years were spent at FDA, where he held several strategic leadership positions and participated in the formulation of FDA guidelines for multiple therapeutic areas. As chief scientist at China's Drug Review Center (CDE) during his tenure, he played a key role in driving several regulatory reforms. Dr. He Ruyi has published over 20 research papers and abstracts in the fields of regulatory science and internal medicine. He obtained a Bachelor's and Master's degree in medicine from China Medical University and a Doctor of Medicine degree in internal medicine from Howard University in the United States. He is a board-certified American internist.
